Zidovudine (Cipla Ltd.)
Welcome to the PulseAid listing for the Zidovudine drug offered from Cipla Ltd.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla Ltd. |
| NON-PROPRIETARY NAME: | Zidovudine |
| SUBSTANCE NAME: | ZIDOVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-10-27 |
| END MARKETING DATE: | 0000-00-00 |
Zidovudine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zidovudine from Cipla Ltd. |
| LABELER NAME: | Cipla Ltd. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/1) |
| START MARKETING DATE: | 2010-10-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53104-0101_036727b4-b9ec-405f-8eaf-bc0931a06f2b |
| PRODUCT NDC: | 53104-0101 |
| APPLICATION NUMBER: | ANDA090561 |
Other ZIDOVUDINE Pharmaceutical Manufacturers / Labelers:
